bf/NASDAQ:RETA_icon.jpeg

NASDAQ:RETA

Reata Pharmaceuticals

  • Stock

USD

Last Close

172.32

25/09 20:00

Market Cap

6.57B

Beta: 1.53

Volume Today

1.91M

Avg: 1.45M

PE Ratio

−81.11

PFCF: −26.32

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
689K
-
-1.45M
310.45%
-6.23M
329.45%
-47.67M
665.55%
-80.55M
68.96%
-290.17M
260.25%
-247.75M
14.62%
-297.39M
20.03%
-311.90M
4.88%
depreciation and amortization
2.51M
-
1.82M
27.59%
682K
62.51%
437K
35.92%
431K
1.37%
932K
116.24%
1.14M
21.89%
1.20M
5.90%
1.13M
6.07%
deferred income tax
1.01M
-
11.18M
-
stock based compensation
1.52M
-
2.08M
36.24%
2.37M
14.07%
6.53M
175.88%
10.55M
61.56%
26.38M
150.06%
57.63M
118.46%
56.81M
1.43%
58.73M
3.39%
change in working capital
-111.87M
-
-64.87M
42.02%
-16.08M
75.21%
-42.69M
165.47%
-16.11M
62.26%
10.33M
164.12%
-172.68M
1,771.34%
-49.58M
71.29%
9.31M
118.78%
accounts receivables
-223K
-
198K
188.79%
inventory
2.36M
-
-603K
125.58%
accounts payables
-1.66M
-
2.75M
266.30%
299K
89.14%
-1.76M
689.63%
1.96M
210.89%
-2.11M
208.13%
2.88M
236.19%
8.71M
202.64%
5.20M
40.31%
other working capital
-109.99M
-
-67.82M
38.34%
-16.38M
75.85%
-40.93M
149.86%
-18.07M
55.85%
12.45M
168.88%
-175.56M
1,510.59%
-58.29M
66.80%
4.11M
107.05%
other non cash items
18.52M
-
17.80M
3.86%
138K
-
888K
543.48%
1.37M
54.73%
28.14M
1,948.25%
53.25M
89.22%
38.46M
27.77%
net cash provided by operating activities
-88.63M
-
-44.62M
49.66%
-19.26M
56.84%
-83.26M
332.30%
-83.78M
0.63%
-251.15M
199.76%
-322.34M
28.35%
-235.70M
26.88%
-204.27M
13.34%
investments in property plant and equipment
-183K
-
-272K
48.63%
-340K
25%
-344K
1.18%
-679K
97.38%
-2.67M
293.67%
-927K
65.32%
-1.33M
43.37%
-3.27M
146.05%
acquisitions net
purchases of investments
-661.89M
-
sales maturities of investments
320M
-
other investing activites
43K
-
12K
72.09%
1K
91.67%
1K
0%
net cash used for investing activites
-140K
-
-260K
85.71%
-339K
30.38%
-343K
1.18%
-679K
97.96%
-2.67M
293.67%
-927K
65.32%
-1.33M
43.37%
-345.16M
25,871.71%
debt repayment
-45K
-
-45K
0%
-45K
0%
-167.17M
-
common stock issued
64.70M
-
108.91M
68.32%
233.50M
114.39%
492.45M
110.90%
333.28M
32.32%
333.28M
0%
common stock repurchased
dividends paid
other financing activites
-825K
-
-2.34M
183.39%
19.78M
946.11%
58.98M
198.13%
87.91M
49.05%
310.99M
253.77%
-324.14M
204.23%
1.49M
100.46%
net cash used provided by financing activities
1K
-
-870K
87,100%
62.32M
7,263.45%
128.65M
106.42%
292.47M
127.34%
580.36M
98.43%
477.09M
17.79%
9.14M
98.08%
1.49M
83.75%
effect of forex changes on cash
net change in cash
-88.77M
-
-45.75M
48.46%
42.72M
193.39%
45.05M
5.44%
208.01M
361.75%
326.53M
56.98%
153.83M
52.89%
-227.89M
248.15%
-547.95M
140.44%
cash at beginning of period
176.53M
-
87.76M
50.29%
42.01M
52.13%
84.73M
101.70%
129.78M
53.17%
337.79M
160.28%
664.32M
96.67%
818.15M
23.16%
590.26M
27.85%
cash at end of period
87.76M
-
42.01M
52.13%
84.73M
101.70%
129.78M
53.17%
337.79M
160.28%
664.32M
96.67%
818.15M
23.16%
590.26M
27.85%
42.31M
92.83%
operating cash flow
-88.63M
-
-44.62M
49.66%
-19.26M
56.84%
-83.26M
332.30%
-83.78M
0.63%
-251.15M
199.76%
-322.34M
28.35%
-235.70M
26.88%
-204.27M
13.34%
capital expenditure
-183K
-
-272K
48.63%
-340K
25%
-344K
1.18%
-679K
97.38%
-2.67M
293.67%
-927K
65.32%
-1.33M
43.37%
-3.27M
146.05%
free cash flow
-88.81M
-
-44.89M
49.45%
-19.60M
56.34%
-83.60M
326.55%
-84.46M
1.03%
-253.82M
200.52%
-323.27M
27.36%
-237.03M
26.68%
-207.54M
12.44%

All numbers in USD (except ratios and percentages)